The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Is Evolving Due To Rising Prevalence Of Arthritis Fueling The Growth Of The Due To Increasing MSK Disease Burden
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market From 2026 To 2030?
The investigational new drug contract development and manufacturing organization (cdmo) market has shown strong expansion in recent years. It is anticipated to increase from $5.91 billion in 2025 to $6.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. The growth observed in the past can be ascribed to factors like the limited availability of CDMOs for investigational drugs, an increasing demand for small molecule synthesis, a reliance on conventional manufacturing services, rising clinical trial volumes, and the early adoption of regulatory support services.
The investigational new drug contract development and manufacturing organization (cdmo) market is projected to experience robust expansion over the coming years. This market is forecast to reach $8.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this anticipated growth include the broadening of gene and cell therapy manufacturing capacities, an increasing need for monoclonal antibodies and recombinant proteins, significant investments in cutting-edge formulation technologies, the implementation of scalable manufacturing platforms, and an uptick in worldwide biotechnology research partnerships. Key trends foreseen during this period encompass a heightened demand for drug development services in their early stages, an expansion of services related to the supply of clinical trial materials, a strengthened emphasis on adherence to regulatory standards and quality benchmarks, the broadening scope of biologics and advanced therapy development, and the integration of tailored manufacturing solutions for both small and large molecules.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25803&type=smp
Which Key Factors Are Driving The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Growth?
The anticipated increase in clinical trials is set to fuel the expansion of the investigational new drug contract development and manufacturing organization (CDMO) market in the future. These trials are meticulously structured studies involving human participants to evaluate the safety and effectiveness of a medical treatment, procedure, or intervention under controlled settings. The primary impetus behind the rise in clinical trials is the escalating demand for innovative treatments, as the growing incidence of chronic and complex diseases prompts pharmaceutical and biotechnology companies to develop and test new therapies. Investigational new drug CDMOs facilitate clinical trials by streamlining the development and manufacturing of trial-ready drug formulations, ensuring a timely and compliant supply of investigational products for each phase of the study. For instance, in December 2024, data from the Association of the British Pharmaceutical Industry, a UK-based pharmaceutical industry trade association, showed that the total number of industry-sponsored clinical trials initiated in the United Kingdom rose from 411 in 2022 to 426 in 2023. Additionally, Phase III trial initiations experienced a 16.5 percent growth over the same period, increasing from 182 to 212. Thus, the growing number of clinical trials is a key driver for the growth of the investigational new drug contract development and manufacturing organization (CDMO) market.
Which Segment Types Are Examined In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Segment Study?
The investigational new drug contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Small Molecules, Large Molecules
2) By Formulation Type: Solid Formulations, Liquid Formulations, Injectable Formulations
3) By Service Type: Clinical Trial Material Supply, Regulatory Support Services, Manufacturing Services
4) By End-User: Biotechnology Companies, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Small Molecules: Synthetic Small Molecules, Semi-synthetic Small Molecules, Peptide-based Small Molecules, Oligonucleotides
2) By Large Molecules: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Cell Therapy Products, Gene Therapy Products, RNA-based Therapeutics
What Trends Are Influencing The Evolution Of The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
Leading companies within the investigational new drug contract development and manufacturing organization (CDMO) market are emphasizing strategic alliances to bolster their development capabilities and expedite clinical entry. Strategic partnerships represent formal agreements between two or more organizations that cooperate to achieve shared objectives, leveraging each other’s strengths, resources, or expertise for mutual gains while remaining distinct entities. For instance, in August 2023, Sartorius AG, a life science company based in Germany, collaborated with Repligen Corporation, a US-based life sciences company, to launch an integrated system combining BIOSTAT STR and XCell ATF technologies for enhanced upstream process intensification. This joint effort aims to streamline biopharmaceutical production through improved efficiency and scalability. The initiative highlights Sartorius’ continuous innovation in bioprocessing solutions, affirming its dedication to advancing the biomanufacturing industry.
Which Players Are Part Of The Competitive Landscape Of The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the investigational new drug contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., Amaran Biotech Inc.
Get The Full Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report:
Where Is The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Most Concentrated Geographically?
North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the investigational new drug contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
